We describe the case of a 65-year-old woman who presented with left nasal obstruction. Clinical and radiographic examinations revealed the presence of a soft -tissue mass that had obliterated the left nasal cavity. Th e mass was completely excised via an endoscopic approach. Histopathologic examination identifi ed the tumor as an ossifying fi brosarcoma. Th e patient recovered uneventfully and remained free of disease at the 2-year postoperative follow-up. To the best of our knowledge, no case of an ossifying fi brosarcoma of the nasal cavity has been previously reported in the English-language literature. We discuss the features of this case and the clinical presentation, diagnosis, and management of fi brosarcomas of the nasal cavity and paranasal sinuses.
Introduction
Fibrosarcomas of the nasal cavity and paranasal sinuses are rare. When they do occur, they oft en present as fi brous polypoid masses that cause nasal obstruction. Most of these tumors are at an advanced stage by the time they are diagnosed. Local recurrence is common, but metastatic spread is unusual.
We report a unique case of a fi bro-osseous neoplasm of the nasal cavity that was diagnosed as low-grade ossifying fi brosarcoma. To the best of our knowledge, this is the fi rst case of an ossifying fi brosarcoma of the nasal cavity to be reported in the English-language literature.
Case report
A 65-year-old woman presented to our rhinology clinic with a complaint of left nasal obstruction of 12 months' evolution and associated headaches and facial pressure. She denied epistaxis, rhinorrhea, and vision problems. Her medical history was remarkable only for hypercholesterolemia. She had no history of radiation therapy or any surgical procedure.
On physical examination, a smooth, pink soft -tissue mass was found to be fi lling the left nasal cavity and extending to the nasal vestibule. Th e patient's extraocular eye movements and visual acuity were normal, and no neck nodes were palpable. Computed tomography (CT) of the paranasal sinuses showed the mass obliterating the left nasal cavity and ethmoid sinus along with remodeling of adjacent bone (fi gure 1). Th e mass had displaced the medial wall of the maxillary sinus laterally and the nasal septum to the opposite side. Magnetic resonance imaging (MRI) of the mass demonstrated an intermediate signal on T1-weighted imaging (fi gure 2) and a homogeneous low-intensity signal on T2-weighting; a mild homogeneous enhancement was seen with gadolinium contrast.
Th e patient was taken to the operating room. On intraoperative inspection, the mass was found to arise from the superomedial surface of the middle turbinate. A complete excision was performed via an endoscopic approach.
Histopathologic examination identifi ed a variable, highly cellular spindle cell tumor with mild atypia and abundant osteoid formation (fi gure 3). Based on these fi ndings, this unusual fi bro-osseous neoplasm was diagnosed as a low-grade ossifying fi brosarcoma. A metastatic workup was negative, and thus no adjuvant therapy was prescribed. Th e patient remained free of disease at the 2-year postoperative follow-up.
the nasal cavity and paranasal sinuses, the maxillary antrum is the most frequently reported site of origin. 2 Th ese neoplasms appear to originate in the periosteum rather than in mucosal connective tissue. 3 Fibrosarcomas are usually unencapsulated, slowly growing spindle cell tumors. 4 Th ey may invade or atrophy adjacent bone by direct pressure. Nasal fi brosarcomas can occur at any age, and the sex distribution is equal. Occasionally, aff ected patients have a history of radiation to the involved area.
Koka et al reported a series of 14 patients with fi brosarcoma and found that 12 of them (86%) had presented with category T4 tumors. 5 Wide local excision was performed in 8 of these patients. In cases of incomplete excision or positive microscopic margins, postoperative radiotherapy was added; the authors reported that adjuvant radiotherapy conferred a signifi cant survival benefi t for patients with T3 and T4 tumors, although their overall 5-year survival was only 21%. Local recurrence was seen in 10 of the 12 patients (83%) with advanced disease. At the latest reported follow-up at 10 years, 11 of the 14 patients (79%) had died of disease.
Fu and Perzin reviewed 256 cases of nonepithelial neoplasms involving the nasal cavity, paranasal sinuses, and nasopharynx. 2 Th ey found 13 cases of fi brosarcoma (5%), but only 4 of these involved the nasal cavity and ethmoid sinus. One of these 4 patients remained free of disease 14 years following radical excision and postoperative radiation. Th e other 3 patients had been treated with surgery alone. Two of them were free of disease at 6 and 10 years, respectively; the third experienced a recurrence 2 years postoperatively and later died of metastatic disease.
Seraj reported a case of an ethmoid fi brosarcoma arising as a frontal mucocele. 6 Th e patient was treated with surgery alone. He experienced a recurrence within 3 years. Despite the paucity of cases of nasal fi brosarcoma in the literature, the initial treatment of choice appears to be wide local excision. Radiotherapy has been used as an adjuvant treatment for incomplete gross excision or positive microscopic margins. Th e role of chemotherapy as a sole treatment for head and neck fi brosarcoma warrants further study. Chemotherapy has been employed as a neoadjuvant treatment in combination with radiotherapy as a palliative measure for patients with unresectable tumors. 5 To the best of our knowledge, our patient represents the fi rst case of ossifying fi brosarcoma of the nasal cavity to be reported in the English-language literature. Th e differential diagnosis for this tumor includes osteosarcoma and ossifying fi broma. Osteosarcomas are also known to produce osteoid. However, the grade of malignancy of this unusual fi bro-osseous tumor is signifi cantly diff erent from what is expected in an osteosarcoma. In our patient, microscopic examination revealed 0 to 1 mitotic fi gure per 10 high-power fi eld without necrosis or infi ltration of the adjacent epithelium. Th e increased and variable cellularity, abundant and irregular osteoid formation, and greater degree of nuclear atypia characteristic of an ossifying fi brosarcoma separate it from an ossifying fi broma.
Lifetime oncologic follow-up for local recurrence and distant metastasis must be performed. 
